Literature DB >> 20201099

Cellular and molecular mechanisms involved in hepatocellular carcinoma gender disparity.

Anna Ruggieri1, Cristiana Barbati, Walter Malorni.   

Abstract

Hepatocellular carcinoma (HCC) represents the most common primary liver cancer and one of the most fatal human cancers. Besides alcoholic liver disease as well as genetic and environmental factors, hepatitis B and C viral infections also represent the most important risk factors for onset and development of the disease. In fact, HCC worldwide prevalence varies widely and mirrors the geographical distribution of chronic viral hepatitis. Interestingly, a gender difference was described for this disease: in almost all populations, a male/female ratio averaging between 2:1 and 4:1 was reported. Here, we analyze the implication of cytokines and sex hormones in this issue. Exploiting the emerging knowledge on the possible differential role of hepatitis viruses B and C, we discuss the role of reactive oxygen species and apoptosis dysregulation in the characterization of the molecular mechanisms of gender disparity in the development of HCC.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20201099     DOI: 10.1002/ijc.25298

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  43 in total

1.  Male-specific W4P/R mutation in the pre-S1 region of hepatitis B virus, increasing the risk of progression of liver diseases in chronic patients.

Authors:  Seoung-Ae Lee; Ki-Jeong Kim; Dong-Won Kim; Bum-Joon Kim
Journal:  J Clin Microbiol       Date:  2013-09-11       Impact factor: 5.948

2.  Genome-wide analysis of chromatin states reveals distinct mechanisms of sex-dependent gene regulation in male and female mouse liver.

Authors:  Aarathi Sugathan; David J Waxman
Journal:  Mol Cell Biol       Date:  2013-07-08       Impact factor: 4.272

3.  SIRT2 maintains genome integrity and suppresses tumorigenesis through regulating APC/C activity.

Authors:  Hyun-Seok Kim; Athanassios Vassilopoulos; Rui-Hong Wang; Tyler Lahusen; Zhen Xiao; Xiaoling Xu; Cuiling Li; Timothy D Veenstra; Bing Li; Hongtao Yu; Junfang Ji; Xin Wei Wang; Seong-Hoon Park; Yong I Cha; David Gius; Chu-Xia Deng
Journal:  Cancer Cell       Date:  2011-10-18       Impact factor: 31.743

4.  Estrogen suppresses hepatocellular carcinoma cells through ERβ-mediated upregulation of the NLRP3 inflammasome.

Authors:  Qing Wei; Pengbo Guo; Kun Mu; Ying Zhang; Wei Zhao; Wanwan Huai; Yumin Qiu; Tao Li; Xiaomin Ma; Yafei Liu; Xiaoyan Chen; Lihui Han
Journal:  Lab Invest       Date:  2015-05-25       Impact factor: 5.662

5.  Sex-Biased lncRNAs Inversely Correlate With Sex-Opposite Gene Coexpression Networks in Diversity Outbred Mouse Liver.

Authors:  Tisha Melia; David J Waxman
Journal:  Endocrinology       Date:  2019-05-01       Impact factor: 4.736

6.  Androgen receptor in hepatocarcinogenesis: Recent developments and perspectives.

Authors:  Y E Tian; X U Xie; Yao Lin; Guang Tan; W U Zhong
Journal:  Oncol Lett       Date:  2015-03-10       Impact factor: 2.967

7.  Reduced 4-aminobiphenyl-induced liver tumorigenicity but not DNA damage in arylamine N-acetyltransferase null mice.

Authors:  Kim S Sugamori; Debbie Brenneman; Otto Sanchez; Mark A Doll; David W Hein; William M Pierce; Denis M Grant
Journal:  Cancer Lett       Date:  2011-12-19       Impact factor: 8.679

8.  Hepatocellular alterations and dysregulation of oncogenic pathways in the liver of transgenic mice overexpressing growth hormone.

Authors:  Johanna G Miquet; Thomas Freund; Carolina S Martinez; Lorena González; María E Díaz; Giannina P Micucci; Elsa Zotta; Ravneet K Boparai; Andrzej Bartke; Daniel Turyn; Ana I Sotelo
Journal:  Cell Cycle       Date:  2013-02-21       Impact factor: 4.534

Review 9.  Androgen receptor roles in hepatocellular carcinoma, fatty liver, cirrhosis and hepatitis.

Authors:  Wen-Lung Ma; Hsueh-Chou Lai; Shuyuan Yeh; Xiujun Cai; Chawnshang Chang
Journal:  Endocr Relat Cancer       Date:  2014-05-06       Impact factor: 5.678

Review 10.  Inflammation- and stress-related signaling pathways in hepatocarcinogenesis.

Authors:  Hayato Nakagawa; Shin Maeda
Journal:  World J Gastroenterol       Date:  2012-08-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.